Carvedilol suppresses malignant proliferation of mammary epithelial cells through inhibition of the ROS-mediated PI3K/AKT signaling pathway

Reactive oxygen species (ROS) cause oncogenic mutations through direct interaction with DNA. Carvedilol (CAR) exhibits antioxidative activity, and pre-clinical studies have identified that CAR may prevent malignant transformation in certain carcinogenic models. This suggests that CAR may be a potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zhongbing, Liu, Xingli, Zhang, Qiang, Yu, Zhigang, Gao, Dezong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312993/
https://www.ncbi.nlm.nih.gov/pubmed/30483797
http://dx.doi.org/10.3892/or.2018.6873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312993/
https://www.ncbi.nlm.nih.gov/pubmed/30483797
http://dx.doi.org/10.3892/or.2018.6873

Ejemplares similares